Results for &quot;&quot;Hyperlipoproteinemia Type IV&quot;&quot;[mesh_terms]

Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review.

Mohamed A Elmonem, Zahraa Ezzeldin, Amanne F Esmael, Dina El-Fayoumi, Yasmeen A Abdo, Nehal M El-Koofy

Lipids in health and disease 2021;20(1):38

Platelet function in patients with familial hypertriglyceridemia: evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles.

L Badimon, J Pedreño, E Hurt-Camejo, L Masana, O Wiklund

Metabolism: clinical and experimental 2000;49(7):942-9

Lipoprotein disorders and cardiovascular risk.

J Genest

Journal of inherited metabolic disease 2004;26(2-3):267-87

Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.

Valmore Bermúdez-Pirela, Aida Souki, Clímaco Cano-Ponce, Fernando Bermúdez-Arias, Edgardo Mengual-Moreno, Elliuz Leal-Gonzalez, Miguel Lemus-Antepaz, Mayela Cabrera de Bravo, Anilsa Amell de Díaz, Nilka Leal de Pirela, Raquel Cano-Peñaloza, Guillermo Puche-Medina, Navlet Arraiz, Nadia Reyna-Villazmil, Freddy Contreras, Zafar H Israili, Manuel Valasco

American journal of therapeutics 2007;14(2):213-20

Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum.

Robert A Hegele, Amit R Rahalkar

Molecular genetics and metabolism 2008;93(3):282-94

Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies.

Giuseppe Danilo Norata, Liliana Grigore, Sara Raselli, Laura Redaelli, Anders Hamsten, Franco Maggi, Per Eriksson, Alberico Luigi Catapano

Atherosclerosis 2007;193(2):321-7

Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.

S S Deeb, A Zambon, J D Brunzell, B G Brown

Journal of internal medicine 2006;259(5):473-80

Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia.

M W Love, A L Craddock, B Angelin, J D Brunzell, W C Duane, P A Dawson

Arteriosclerosis, thrombosis, and vascular biology 2002;21(12):2039-45

Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men.

Cristina Hernández, Albert Lecube, Gloria Barberá, Pilar Chacón, Joan Lima, Rafael Simó

Medical science monitor : international medical journal of experimental and clinical research 2003;9(3):CR114-9

Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.

Catherine N Vu, Raul Ruiz-Esponda, Eric Yang, Evelyn Chang, Baiba Gillard, Henry J Pownall, Ron C Hoogeveen, Ivonne Coraza, Ashok Balasubramanyam

Metabolism: clinical and experimental 2013;62(7):1014-20

Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia.

Päivi Pajukanta, Teresa Tusie-Luna, Carlos A Aguilar-Salinas

Metabolism: clinical and experimental 2014;63(7):887-94